REVANCE THERAPEUTICS INC shareholders Q3 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NORTHERN TRUST CORP 838,356$9,615,9430.00%
GEODE CAPITAL MANAGEMENT, LLC 1,780,277$20,422,4020.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 23,860$2740.00%
CAPITAL FUND MANAGEMENT S.A. 41,900$480,5930.00%
CREDIT SUISSE AG/ 140,615$1,612,8540.00%
CITIGROUP INC 184,800$2,119,6560.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 663,538$7,610,7810.00%
WELLINGTON MANAGEMENT GROUP LLP 1,082,420$12,415,3580.00%
BlackRock Inc. 6,756,720$77,499,5790.00%
J.P. Morgan Private Wealth Advisors LLC 54,329$623,1540.00%
DekaBank Deutsche Girozentrale 86,100$1,0120.00%
DnB Asset Management AS 23,946$274,6610.00%
HRT FINANCIAL LP 14,364$1640.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 23,811$273,1120.00%
UBS ASSET MANAGEMENT AMERICAS INC 110,675$1,269,4430.00%
Mirae Asset Global Investments Co., Ltd. 37,897$434,6790.00%
Capital Advisors, Ltd. LLC 760$90.00%
Ensign Peak Advisors, Inc 37,000$424,3900.00%
ProShare Advisors LLC 16,586$190,2420.00%
MILLENNIUM MANAGEMENT LLC 100,000$1,147,0000.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.